Charlottte (Talk | contribs) |
Charlottte (Talk | contribs) |
||
Line 138: | Line 138: | ||
.nav { | .nav { | ||
position:relative; | position:relative; | ||
− | width: | + | width: 103%; |
text-align: center; | text-align: center; | ||
} | } |
Latest revision as of 18:26, 28 November 2016
Non-small cell lung cancer (NSCLC)
While Lung cancer is a common kind of cancer, non-small cell lung cancer belongs to lung cancer and takes the percentage of 80%-85% .Unlike most lung cancer , non-small cell cancer usually appears to occur in people who do not smoke.
According to the WHO Health statistics [1], the death rate of lung cancer is on the top among cancers. In particular, it is the leading cause of cancer death among males in both developed and undeveloped countries.
![](https://static.igem.org/mediawiki/parts/a/aa/Wiki_project_1.jpg)
Figure 1. Death rate among cancers around the world, according to WHO Health statistics.
Therapy for NSCLC
![](https://static.igem.org/mediawiki/parts/7/77/Wiki_project_2.png)
Figure 2. According to Nccn clinical practice guidelines in oncology, non-small cell cancer. Current therapy for NSCLC[2], mainly consists of traditional therapy, small-molecule targeted drugs and cancer immunotherapy.